Association of antibiotic exposure with residual cancer burden in HER2-negative early stage breast cancer

ISPY2 consortium

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Association of antibiotic exposure with residual cancer burden in HER2-negative early stage breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences